LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | - | ₹1.07 Cr | ₹2.00 Cr | ₹2.04 Cr | ₹0.52 Cr |
What is the latest Total Debt ratio of LINCOLN PHARMACEUTICALS ?
| Year | Total Debt |
|---|---|
| Mar2025 | - |
| Mar2024 | ₹1.07 Cr |
| Mar2023 | ₹2.00 Cr |
| Mar2022 | ₹2.04 Cr |
| Mar2021 | ₹0.52 Cr |
How is Total Debt of LINCOLN PHARMACEUTICALS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹1.07 Cr | -46.57 | |
| Mar2023 | ₹2.00 Cr | -2.30 | |
| Mar2022 | ₹2.04 Cr | 293.08 | |
| Mar2021 | ₹0.52 Cr | - | |
Compare Total Debt of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,250.9 Cr | 3.3% | 1.6% | 12% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,048.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,179.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,804.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,642.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,368.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 3.3% |
1.6% |
12% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses